部落格

An ráta marthanais a mhéadú | Carcinoma adrenocortical | Céim 0 | Céim 1 | Céim 2 | Céim 3 | Céim 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

An ráta marthanais a mhéadú | Carcinoma adrenocortical | Céim 0 | Céim 1 | Céim 2 | Céim 3 | Céim 4

Read more →


An ráta marthanais a mhéadú | Géar leoicéime lymphoblaisteach | Leoicéime géarmhíochaine lymphocytic | Céim 0 | Céim 1 | Céim 2 | Céim 3 | Céim 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

An ráta marthanais a mhéadú | Géar leoicéime lymphoblaisteach | Leoicéime géarmhíochaine lymphocytic | Céim 0 | Céim 1 | Céim 2 | Céim 3 | Céim 4

Read more →


Öka överlevnadsgraden | Wilms tumör | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Wilms tumör | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Waldenström makroglobulinemi | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Waldenström makroglobulinemi | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Vulvarcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Vulvarcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Vaginal cancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Vaginal cancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Livmodersarkom | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Livmodersarkom | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Urinrörscancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Urinrörscancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Tumör | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Tumör | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Sköldkörtelcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Sköldkörtelcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Thymoma | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Thymoma | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Hals cancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Hals cancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Testikelcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Testikelcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | T-celllymfom | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | T-celllymfom | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Supratentorial primitiv neuroektodermal tumör | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Supratentorial primitiv neuroektodermal tumör | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Skivepitelcancer | SCC | Epidermoidkarcinom | Skivepitelepitel | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Skivepitelcancer | SCC | Epidermoidkarcinom | Skivepitelepitel | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Mjukvävnadssarkom | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Mjukvävnadssarkom | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Tunntarmscancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Tunntarmscancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Förbättra botningshastigheten effektivt. | Öka överlevnadsgraden. | Småcells lungcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Solamargine modulerar cancercellernas antimodulerande gener, vilket gör cancerceller mindre motståndskraftiga. | Minskad läkemedelsresistens (Reducera resistens). | När cancerceller är mindre resistenta mot läkemedel blir kemoterapi effektivare.

Förbättra botningshastigheten effektivt. | Öka överlevnadsgraden. | Småcells lungcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →


Öka överlevnadsgraden | Hudkarcinom | Hudcancer | Hudcancer | Hudcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract

Öka överlevnadsgraden | Hudkarcinom | Hudcancer | Hudcancer | Hudcancer | Steg 0 | Steg 1| Steg 2 | Steg 3 | Steg 4

Read more →